← All stocks

BiomX Inc.

PHGE Scheduled selling only
CIK 0001739174 #5600 in the set updated 19 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$8.25M
$0.00 on a plan · $8.25M straight out of an exercise
Sold at will
$0.00
0 of 4 sales
Net
−$8.25M
$0.00 against sales at will

By person

5 insiders · 5 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Yeganeh Reuven
Director
$8.25M (4) scheduled
−$8.25M
0
$0.00
Flynn James E
Director
1,247,054
$6.24M
+130.7%
Solomon Jonathan Eitan
Chief Executive Officer
126,748
$633.74K
Bassan Merav
Chief Development Officer
79,597
$397.99K
Wolfson Marina
Chief Financial Officer
68,545
$342.73K

No percentages here. This company's share count has moved by a factor of 2.9 over the window, from 10,111,516 to 29,006,165 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Yeganeh Reuven
17 Mar 2026
Director
Sold after exercise indirect
530,000
$5.00
$2.65M
Yeganeh Reuven
16 Mar 2026
Director
Sold after exercise indirect
450,000
$5.00
$2.25M
Yeganeh Reuven
13 Mar 2026
Director
Sold after exercise indirect
370,000
$5.00
$1.85M
Yeganeh Reuven
12 Mar 2026
Director
Sold after exercise indirect
300,000
$5.00
$1.50M

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 4
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,650,000
History held since 19 Dec 2018